Knowledge Base Topics

SPFH domain1 actin dynamics1 RhoA1 Cdc421 ROCK1 PAK1 Arp2/31 Arylnitrile1 ABCAs1 azabicyclo[x.1.1]alkanes1 PLSCR family1 PLSCR11 phospholipid scramblase1 PS externalization1 platelet activation1 interferon response1 GIPR1 incretin1 glucagon1 dual receptor agonist1 KLK1 kallikrein-related peptidase1 proteolytic cascade1 CD1311 CSF2RB1 IL-31 JAK21 STAT51 βc family1 common β chain1 hematopoietic regulation1 myeloid cells1 Targeted Covalent Inhibitors1 Covalent Drugs1 Covalent Warheads1 Reversible Covalent Inhibition1 Irreversible Covalent Inhibition1 Covalent Kinetics1 Chemical Proteomics1 SUMOylation1 Protein Post-Translational Modifications1 Ubiquitination1 Acetylation1 Lactylation1 Modification Proteomics1 Peptide Drugs1 Peptide Hormones1 Natural Bioactive Peptides1 Peptide Vaccines1 Peptide Modification1 ENTPD31 NTPDase31 CD39L31 extracellular ATP1 extracellular ADP1 Purinergic Signaling1 Islet β Cells1 Insulin Secretion1 Diabetes1 VHH1 Heavy-Chain-Only Antibody1 Multivalency1 Multispecificity1 Tumor Imaging1 Antibody Library1 NRAS1 HRAS1 RAS(ON)1 small GTPase1 molecular glue1 Centella asiatica Water1 BCB1 bicyclo[1.1.0]butane1 Aβ1 Tau1 BACE11 Heterobicyclo[n.1.1]alkanes1 Tea Polyphenols1 trimethylsilyl chloride1 TMSCl1 N,N-dimethylformamide1 DMF1 Thietanes1 HMGB11 DAMP1 TLR41 RAGE1 CXCL121 damage-associated molecular pattern1 tumor stemness1 chemoresistance1 Tumor Organoid1 Patient-Derived Organoid1 Tumor Heterogeneity1 Malignant Identity Characterization1 Precision Therapy1 IGFBP1 IGF-I1 IGF-II1 IGF1R1